ETHZilla Corporation (ETHZ) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.82
• Market Cap: $74.34M
• EPS: $-182.51
• 52-Week High: $127.40
• 52-Week Low: $2.99

Market Sentiment

ETHZilla Corporation currently has a Neutral sentiment score of 0.11.

About ETHZilla Corporation

ETHZilla Corporation is a clinical-stage biotechnology firm based in Palm Beach, Florida, focused on developing innovative therapeutics for chronic pain, inflammation, fibrosis, and various inflammatory diseases. The company is dedicated to addressing significant unmet medical needs through its advanced pipeline of novel drug candidates, which promise to enhance patient outcomes in underserved therapeutic areas. With a strong commitment to research and development, ETHZilla aims to leverage c...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for ETHZilla Corporation and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ETHZ pay dividends?

ETHZilla Corporation (ETHZ) does not currently pay a regular dividend.

What is ETHZ's market cap?

ETHZilla Corporation (ETHZ) has a market capitalization of $74.34M with a current stock price of $3.82.